200 related articles for article (PubMed ID: 36940016)
1. In Silico Analysis of a Candidate Multi-epitope Peptide Vaccine Against Human Brucellosis.
Yazdani Z; Rafiei A; Ghoreyshi M; Abediankenari S
Mol Biotechnol; 2024 Apr; 66(4):769-783. PubMed ID: 36940016
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
Jalal K; Khan K; Uddin R
Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
[TBL] [Abstract][Full Text] [Related]
3. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
Saadi M; Karkhah A; Nouri HR
Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
5. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
[TBL] [Abstract][Full Text] [Related]
7. Design of a new multi-epitope vaccine against
Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
[TBL] [Abstract][Full Text] [Related]
8. Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS).
Yin Z; Li M; Niu C; Yu M; Xie X; Haimiti G; Guo W; Shi J; He Y; Ding J; Zhang F
PLoS One; 2023; 18(8):e0286358. PubMed ID: 37561685
[TBL] [Abstract][Full Text] [Related]
9. In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD.
Shi J; Zhu Y; Yin Z; He Y; Li Y; Haimiti G; Xie X; Niu C; Guo W; Zhang F
Sci Rep; 2024 Mar; 14(1):7278. PubMed ID: 38538674
[TBL] [Abstract][Full Text] [Related]
10. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
Bundle DR; McGiven J
Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
[TBL] [Abstract][Full Text] [Related]
12. Epitope-Based Vaccine of a
Oliveira KC; Brancaglion GA; Santos NCM; Araújo LP; Novaes E; Santos RL; Oliveira SC; Corsetti PP; de Almeida LA
Front Immunol; 2021; 12():778475. PubMed ID: 34992597
[No Abstract] [Full Text] [Related]
13. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
[TBL] [Abstract][Full Text] [Related]
14. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
[TBL] [Abstract][Full Text] [Related]
15. Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella.
Li Z; Zhang F; Zhang C; Wang C; Lu P; Zhao X; Hao L; Ding J
Mol Immunol; 2019 Oct; 114():651-660. PubMed ID: 31557626
[TBL] [Abstract][Full Text] [Related]
16. Novel multi-epitope vaccine against bovine brucellosis: approach from immunoinformatics to expression.
Rahimnahal S; Yousefizadeh S; Mohammadi Y
J Biomol Struct Dyn; 2023; 41(24):15460-15484. PubMed ID: 36927475
[TBL] [Abstract][Full Text] [Related]
17. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
Aziz S; Almajhdi FN; Waqas M; Ullah I; Salim MA; Khan NA; Ali A
Front Immunol; 2022; 13():1004804. PubMed ID: 36311762
[TBL] [Abstract][Full Text] [Related]
18. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
Ahmad S; Ranaghan KE; Azam SS
Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
[TBL] [Abstract][Full Text] [Related]
19. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
Nain Z; Karim MM; Sen MK; Adhikari UK
Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine.
Yang Y; Wang L; Yin J; Wang X; Cheng S; Lang X; Wang X; Qu H; Sun C; Wang J; Zhang R
Mol Immunol; 2011 Oct; 49(1-2):175-84. PubMed ID: 21943783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
